These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32313061)

  • 1. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease.
    Jaminon AMG; Dai L; Qureshi AR; Evenepoel P; Ripsweden J; Söderberg M; Witasp A; Olauson H; Schurgers LJ; Stenvinkel P
    Sci Rep; 2020 Apr; 10(1):6586. PubMed ID: 32313061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Pottel H; Cavalier E
    BMC Nephrol; 2014 Sep; 15():145. PubMed ID: 25190488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.
    Liabeuf S; Bourron O; Olivier B; Vemeer C; Theuwissen E; Magdeleyns E; Aubert CE; Brazier M; Mentaverri R; Hartemann A; Massy ZA
    Cardiovasc Diabetol; 2014 Apr; 13():85. PubMed ID: 24762216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
    Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
    Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study.
    Dai L; Li L; Erlandsson H; Jaminon AMG; Qureshi AR; Ripsweden J; Brismar TB; Witasp A; Heimbürger O; Jørgensen HS; Barany P; Lindholm B; Evenepoel P; Schurgers LJ; Stenvinkel P
    PLoS One; 2021; 16(2):e0247623. PubMed ID: 33626087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
    Berlot AA; Fu X; Shea MK; Tracy R; Budoff M; Kim RS; Naveed M; Booth SL; Kizer JR; Bortnick AE
    Atherosclerosis; 2024 May; 392():117505. PubMed ID: 38527383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.
    Schurgers LJ; Barreto DV; Barreto FC; Liabeuf S; Renard C; Magdeleyns EJ; Vermeer C; Choukroun G; Massy ZA
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):568-75. PubMed ID: 20133489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk.
    Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients.
    Fain ME; Kapuku GK; Paulson WD; Williams CF; Raed A; Dong Y; Knapen MHJ; Vermeer C; Pollock NK
    Am J Hypertens; 2018 May; 31(6):735-741. PubMed ID: 29635270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
    Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
    Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
    Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
    PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
    Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
    Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
    Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
    Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients.
    Cranenburg EC; Brandenburg VM; Vermeer C; Stenger M; Mühlenbruch G; Mahnken AH; Gladziwa U; Ketteler M; Schurgers LJ
    Thromb Haemost; 2009 Feb; 101(2):359-66. PubMed ID: 19190822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Levels of Dephosphorylated-Uncarboxylated Matrix Gla Protein in Patients with Acute Coronary Syndrome.
    Bilalic A; Ticinovic Kurir T; Kumric M; Borovac JA; Matetic A; Supe-Domic D; Bozic J
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33669806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.